The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Mode of Selection and Experimental Evolution of Antifungal Drug Resistance in Saccharomyces cerevisiae
Abstract
We show that mode of selection, degree of dominance of mutations, and ploidy are determining factors in the evolution of resistance to the antifungal drug fluconazole in yeast. In experiment 1, yeast populations were subjected to a stepwise increase in fluconazole concentration over 400 generations. Under this regimen, two mutations in the same two chromosomal regions rose to high frequency in parallel in three replicate populations. These mutations were semidominant and additive in their effect on resistance. The first of these mutations mapped to PDR1 and resulted in the overexpression of the ABC transporter genes PDR5 and SNQ2. These mutations had an unexpected pleiotropic effect of reducing the residual ability of the wild type to reproduce at the highest concentrations of fluconazole. In experiment 2, yeast populations were subjected to a single high concentration of fluconazole. Under this regimen, a single recessive mutation appeared in each of three replicate populations. In a genome-wide screen of approximately 4700 viable deletion strains, 13 were classified as resistant to fluconazole (ERG3, ERG6, YMR102C, YMR099C, YPL056C, ERG28, OSH1, SCS2, CKA2, SML1, YBR147W, YGR283C, and YLR407W). The mutations in experiment 2 all mapped to ERG3 and resulted in the overexpression of the gene encoding the drug target ERG11, but not PDR5 and SNQ2. Diploid hybrids from experiments 1 and 2 were less fit than the parents in the presence of fluconazole. In a variation of experiment 2, haploids showed a higher frequency of resistance than diploids, suggesting that degree of dominance and ploidy are important factors in the evolution of antifungal drug resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impact of drug concentration on the spectrum and effect of mutations acquired during adaptation is not known for any fungal pathogen, and how the specific level of a given stress influences the distribution of beneficial mutations has been poorly explored in general.”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Anderson et al. 2003
In the citing paper
“In a similar example, three lineages from one genetic background of haploid S. cerevisiae were exposed to increasing concentrations of FLC over the span of 400 generations, starting at 16 μg/ml FLC and increasing every 100 generations to 32 μg/ml, 64 μg/ml, and 128 μg/ml FLC (Anderson et al. 2003).”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Anderson et al. 2003
In the citing paper
“Prior studies into how antifungal drugs impact the spectrum of mutations observed during adaption primarily focused on increasing FLC concentrations or on short-term evolution experiments in a single concentration of FLC (Cowen et al. 2000; Anderson et al. 2003; Mount et al. 2018; Rybak et al. 2020; Burrack et al. 2022).”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Anderson et al. 2003
In the citing paper
“Overall, the impact of genetic and environmental factors, including FLC concentration, on the acquisition of drug resistance and tolerance phenotypes is not known.”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Anderson et al. 2003
In the citing paper
“Several studies have shown a high consistency between results obtained in vivo and in vitro in yeasts like C. albicans and S. cerevisiae [147,148].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [148]
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Jacob, H. (1988) · Bioelectrochemistry and Bioenergetics · doi:10.1016/0302-4598(88)80052-7 · Cited by 4,911
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R. B., Armour, C. D., Bennett, H. A., Coffey, E. M., Dai, H. A., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,534
New heterologous modules for classical or PCR‐based gene disruptions in Saccharomyces cerevisiae
Wach, A., Brachat, A., Pöhlmann, R., & Philippsen, P. (1994) · Yeast · doi:10.1002/yea.320101310 · Cited by 2,532
The biological cost of antibiotic resistance
Andersson, D. I., & Levin, B. R. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00005-3 · Cited by 861
Levin, B. R., Perrot, V., & Walker, N. (2000) · Genetics · doi:10.1093/genetics/154.3.985 · Cited by 630
Bakers' Yeast, a Model for Fungal Biofilm Formation
Reynolds, T. B., & Fink, G. R. (2001) · Science · doi:10.1126/science.291.5505.878 · Cited by 585
Molecular basis of resistance to azole antifungals.
Lupetti, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02280-3 · Cited by 449
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., et al. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.643-658.2001 · Cited by 444
FunSpec: a web-based cluster interpreter for yeast
Robinson, M. D., Grigull, J., Mohammad, N., & Hughes, T. R. (2002) · BMC Bioinformatics · doi:10.1186/1471-2105-3-35 · Cited by 410
The Evolutionary Biology and Population Genetics Underlying Fungal Strain Typing
Taylor, J. W., Geiser, D. M., Burt, A., & Koufopanou, V. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.126 · Cited by 338
[2] Micromanipulation and dissection of asci
Sherman, F., & Hicks, J. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)94005-w · Cited by 305
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
DeRisi, J. L., van den Hazel, B., Marc, P., Balzi, E., Brown, P. O., Jacq, C., & Goffeau, A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01294-1 · Cited by 276
Overlapping Functions of the Yeast Oxysterol-Binding Protein Homologues
Beh, C. T., Cool, L. G., Phillips, J., & Rine, J. (2001) · Genetics · doi:10.1093/genetics/157.3.1117 · Cited by 272
Human Mycoses: Drugs and Targets for Emerging Pathogens
Georgopapadakou, N. H., & Walsh, T. J. (1994) · Science · doi:10.1126/science.8153622 · Cited by 231
Evolution of Drug Resistance in Experimental Populations of Candida albicans
Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., & Kohn, L. M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1515-1522.2000 · Cited by 207
Self-citationEvolution of Drug Resistance in Candida Albicans
Cowen, L. E., Anderson, J. B., & Kohn, L. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160907 · Cited by 151
Does diploidy increase the rate of adaptation?
Orr, H. A., & Otto, S. P. (1994) · Genetics · doi:10.1093/genetics/136.4.1475 · Cited by 149
The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH Dependent
Marr, K. A., Rustad, T. R., Rex, J. H., & White, T. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1383 · Cited by 145
Population genomics of drug resistance in Candida albicans
Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., & Anderson, J. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102291099 · Cited by 140
Self-citationRegulation of pleiotropic drug resistance in yeast
Kołaczkowska, A., & Goffeau, A. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0113 · Cited by 123
Cowen, L. E., Kohn, L. M., & Anderson, J. B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.10.2971-2978.2001 · Cited by 116
Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., & Moreillon, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2932-2938.2000 · Cited by 113
Kagiwada, S., Hosaka, K., Murata, M., Nikawa, J., & Takatsuki, A. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.7.1700-1708.1998 · Cited by 106
Multiple resistance mechanisms to azole antifungals in yeast clinical isolates
Sanglard, D., Ischer, F., Calabrese, D. R., de Micheli, M., & Billé, J. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80006-x · Cited by 97
Sato, M., Fujisaki, S., Sato, K., Nishimura, Y., & Nakano, A. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00438.x · Cited by 85
A novel gene conserved from yeast to humans is involved in sterol biosynthesis
Gachotte, D. J., Eckstein, J. A., Barbuch, R. J., Hughes, T. R., Roberts, C., & Bard, M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32347-6 · Cited by 84
Functional dissection of Pdr1p, a regulator of multidrug resistance in Saccharomyces cerevisiae
Kołaczkowska, A., Kołaczkowski, M., Delahodde, A., & Goffeau, A. (2002) · Molecular Genetics and Genomics · doi:10.1007/s00438-002-0642-0 · Cited by 40
Antifungal susceptibility testing of yeasts: uses and limitations
Reyes, G. H., & Ghannoum, M. A. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0127 · Cited by 18
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Paltauf, 1992, Regulation and compartmentalization of lipid synthesis in yeast, 415
Cited by
Sorted by citations
The Evolutionary Consequences of Polyploidy
Otto, S. P. (2007) · Cell · doi:10.1016/j.cell.2007.10.022 · Cited by 1,225
The genetic theory of adaptation: a brief history
Orr, H. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1523 · Cited by 1,153
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Self-citationCandidiasis and Mechanisms of Antifungal Resistance
Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020) · Antibiotics · doi:10.3390/antibiotics9060312 · Cited by 474
Metadata
- Authors
- Anderson, J. B., Sirjusingh, C., Parsons, A. B., Boone, C., Wickens, C., Cowen, L. E., & Kohn, L. M.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Anderson, James B
- Venue
- Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 163
- Issue
- 4
- Pages
- 1287-1298
- ISSN
- 0016-6731 (ISSN-L)
- 1943-2631
- OpenAlex
- W2143154997
- Cited by
- 156
- References
- 31
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 11 · 2020: 10 · 2019: 10 · 2018: 5 · 2017: 10 · 2016: 5 · 2015: 6 · 2014: 10 · 2013: 5 · 2012: 10
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Keywords
- antifungal resistance, fluconazole resistance, Saccharomyces cerevisiae, experimental evolution, ploidy, PDR1, PDR5, ERG3, ERG11, pleiotropy
- MeSH terms
- Diploidy, Dose-Response Relationship, Drug, Biological Evolution, Haploidy, Saccharomyces cerevisiae, Selection, Genetic, Fluconazole, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
